Machado Clarence Patrick
Insider CIK 1311210 · MDVN Chief Business Officer and CFO, Director · CMRX Director · SCYX Director · ECYT Director · ITEK Director · ABUS 10% owner · ADVM Director · PRNB Director · XENE Director · TPTX Director · AXON Director, 10% owner · MYOV 10% owner · RCUS Director · UROV 10% owner · ALMS Director · SLRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALMS ALUMIS INC. | A Award deriv | 2026-06-30 | 2026-07-02 | 15,528 | — | $0 | 15,528 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2026-06-30 | 2026-07-02 | 3,553 | — | $0 | 3,553 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 16,900 | — | $0 | 16,900 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2026-06-11 | 2026-06-12 | 5,700 | — | $0 | 44,300 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-06-03 | 2026-06-03 | 10,507 | — | $0 | 10,507 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-06-03 | 2026-06-03 | 1,593 | — | $0 | 1,593 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-06-01 | 2026-06-03 | 2,645 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-06-01 | 2026-06-03 | 2,645 | — | $0 | 2,645 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 1,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,360 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 6,476 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 4,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 1,500 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 3,000 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 5,250 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 5,250 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 5,250 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 13,820 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | D To issuer deriv | 2025-12-09 | 2025-12-10 | 13,590 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | U Tender | 2025-12-09 | 2025-12-10 | 8,818 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-30 | 2025-08-01 | 49,800 | — | $0 | 49,800 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 10,450 | — | $0 | 10,450 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2025-06-17 | 2025-06-20 | 3,140 | — | $0 | 3,140 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 38,300 | — | $0 | 38,300 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 13,300 | — | $0 | 38,600 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 2,645 | — | $0 | 2,645 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 17,012 | — | $0 | 17,012 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-05-21 | 2025-05-23 | 44,364 | — | $0 | 44,364 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-05-21 | 2025-05-23 | 19,528 | — | $0 | 19,528 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-05-21 | 2025-05-23 | 13,804 | — | $0 | 13,804 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-05-21 | 2025-05-23 | 41,499 | — | $0 | 41,499 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-05-21 | 2025-05-23 | 11,189 | — | $0 | 11,189 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 92,158 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 28,675 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 86,206 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 40,567 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 23,243 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2025-05-21 | 2025-05-23 | 7,064 | — | $0 | 7,064 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 14,675 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 38,000 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-06-27 | 2024-07-01 | 38,000 | — | $0 | 38,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-06-17 | 2024-06-20 | 3,300 | — | $0 | 3,300 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2024-06-17 | 2024-06-20 | 10,520 | — | $0 | 10,520 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 92,158 | — | $0 | 92,158 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2024-06-06 | 2024-06-07 | 8,400 | — | $0 | 25,300 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-06-05 | 2024-06-05 | 15,542 | — | $0 | 15,542 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other | 2023-10-04 | 2023-10-06 | 14,675 | — | $0 | 14,675 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2023-06-15 | 2023-06-16 | 6,800 | — | $0 | 16,900 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2023-06-09 | 2023-06-12 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-06-09 | 2023-06-13 | 12,500 | — | $0 | 52,500 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2023-06-09 | 2023-06-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-06-02 | 2023-06-02 | 18,475 | — | $0 | 18,475 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 86,206 | — | $0 | 86,206 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 40,567 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 40,567 | — | $0 | 40,567 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 86,206 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 23,243 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 28,675 | — | $0 | 28,675 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 28,675 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 23,243 | — | $0 | 23,243 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 8,500 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 8,500 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 30,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-06-28 | 2022-06-29 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2022-06-23 | 2022-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 16,800 | — | $0 | 16,800 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2022-06-14 | 2022-06-16 | 4,100 | — | $0 | 10,100 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-06-10 | 2022-06-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2022-06-10 | 2022-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2021-06-23 | 2021-06-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-06-03 | 2021-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2021-06-03 | 2021-06-07 | 14,100 | — | $0 | 14,100 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2021-06-03 | 2021-06-07 | 3,000 | — | $0 | 6,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-06-02 | 2021-06-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-05-12 | 2021-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2021-05-12 | 2021-05-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-03-24 | 2021-03-24 | 10,000 | $9.92 | $99.2K | 88,182 | SEC↗ |
| ADVM Adverum Biotechnologies, I | P Buy | 2021-01-15 | 2021-01-19 | 10,000 | $11.52 | $115.2K | 78,182 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2020-11-05 | 2020-11-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 20,475 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 10,240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 10,240 | — | $0 | 0 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-06-23 | 2020-06-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-06-15 | 2020-06-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2020-06-11 | 2020-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 10,240 | — | $0 | 10,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2020-06-04 | 2020-06-08 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2020-01-01 | 2020-01-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-12-10 | 2019-12-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2019-07-31 | 2019-08-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2019-06-20 | 2019-06-24 | 21,000 | — | $0 | 21,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-06-11 | 2019-06-11 | 20,475 | — | $0 | 20,475 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-06-11 | 2019-06-11 | 10,240 | — | $0 | 10,240 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 2,424,242 | $8.25 | $20.00M | 40,765,599 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 22,723,562 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 22,725,277 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 22,715,277 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2019-05-13 | 2019-05-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2019-03-18 | 2019-03-19 | 6,666,667 | $1.50 | $10.00M | 105,952,381 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2019-01-02 | 2019-01-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 22,500 | $19.80 | $445.5K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 1,250 | $24.00 | $30.0K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 2,500 | $24.00 | $60.0K | 0 | SEC↗ |
| ECYT ENDOCYTE INC | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-12-18 | 2018-12-20 | 10,000,000 | $1.00 | $10.00M | 99,285,714 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2018-10-01 | 2018-10-03 | 2,678,571 | $14.00 | $37.50M | 22,703,669 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2018-06-20 | 2018-06-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-06-05 | 2018-06-07 | 14,285,714 | $1.75 | $25.00M | 89,285,714 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2018-05-31 | 2018-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 7,050 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2018-04-02 | 2018-04-04 | 1,110,015 | $20.27 | $22.50M | 38,341,357 | SEC↗ |
| ECYT ENDOCYTE INC | A Award deriv | 2018-02-27 | 2018-03-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ECYT ENDOCYTE INC | A Award | 2018-02-27 | 2018-03-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2018-02-15 | 2018-02-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2018-01-12 | 2018-01-16 | 664,000 | $100.00 | $66.40M | 1,164,000 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2018-01-02 | 2018-01-04 | 19,989 | — | $0 | 19,989 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2017-10-16 | 2017-10-17 | 500,000 | $100.00 | $50.00M | 500,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2017-07-17 | 2017-07-19 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2017-06-28 | 2017-06-29 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2017-06-20 | 2017-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2017-06-12 | 2017-06-14 | 33,602 | — | $0 | 33,602 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2017-06-12 | 2017-06-14 | 22,727 | — | $0 | 68,182 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2017-03-14 | 2017-03-16 | 64,767 | — | $0 | 64,767 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2017-03-14 | 2017-03-16 | 45,455 | — | $0 | 45,455 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2017-01-03 | 2017-01-05 | 14,499 | — | $0 | 14,499 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 90,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 222,800 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 264,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 33,336 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 70,792 | — | $0 | 0 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2016-09-15 | 2016-09-16 | 40,000 | $2.94 | $117.6K | 60,000 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2016-08-17 | 2016-08-18 | 24,000 | — | $0 | 24,000 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy deriv | 2016-06-24 | 2016-06-28 | 9,000 | $0.02 | $180 | 9,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2016-06-24 | 2016-06-28 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SCYX SCYNEXIS INC | P Buy | 2016-06-24 | 2016-06-28 | 20,000 | $2.39 | $47.8K | 20,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 70,792 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2016-06-02 | 2016-06-06 | 8,800 | $3.98 | $35.0K | 8,800 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2016-01-19 | 2016-01-21 | 75,000 | — | $0 | 33,336 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-01-19 | 2016-01-21 | 37,021 | $36.62 | $1.36M | 104,135 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-01-19 | 2016-01-21 | 6,950 | $39.19 | $272.4K | 66,156 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-01-19 | 2016-01-21 | 23,087 | $37.50 | $865.8K | 81,048 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-01-19 | 2016-01-21 | 7,942 | $38.62 | $306.7K | 73,106 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2016-01-19 | 2016-01-21 | 75,000 | $3.37 | $252.8K | 141,156 | SEC↗ |
| CMRX CHIMERIX INC | P Buy | 2015-12-29 | 2015-12-30 | 10,000 | $7.08 | $70.8K | 10,000 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2015-09-25 | 2015-09-28 | 71,980 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-09-25 | 2015-09-28 | 22,236 | $41.63 | $925.7K | 104,300 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-09-25 | 2015-09-28 | 20,464 | $42.68 | $873.4K | 83,836 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2015-09-25 | 2015-09-28 | 71,980 | $4.69 | $337.6K | 138,136 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-09-25 | 2015-09-28 | 17,680 | $43.92 | $776.5K | 66,156 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-09-25 | 2015-09-28 | 11,600 | $40.82 | $473.5K | 125,536 | SEC↗ |
| SCYX SCYNEXIS INC | A Award deriv | 2015-09-24 | 2015-09-28 | 11,700 | — | $0 | 11,700 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2015-06-22 | 2015-06-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 33,078 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2015-06-04 | 2015-06-08 | 36,000 | — | $0 | 35,990 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-06-04 | 2015-06-08 | 300 | $120.04 | $36.0K | 31,500 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2015-06-04 | 2015-06-08 | 36,000 | $9.39 | $338.0K | 67,500 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-06-04 | 2015-06-08 | 16,600 | $116.12 | $1.93M | 50,900 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-06-04 | 2015-06-08 | 2,900 | $117.10 | $339.6K | 48,000 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-06-04 | 2015-06-08 | 6,600 | $118.38 | $781.3K | 41,400 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-06-04 | 2015-06-08 | 9,600 | $119.06 | $1.14M | 31,800 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2015-02-10 | 2015-02-12 | 36,000 | — | $0 | 71,990 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-02-10 | 2015-02-12 | 700 | $101.27 | $70.9K | 66,800 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2015-02-10 | 2015-02-12 | 36,000 | $9.39 | $338.0K | 67,500 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-02-10 | 2015-02-12 | 3,400 | $102.37 | $348.1K | 63,400 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-02-10 | 2015-02-12 | 20,700 | $104.35 | $2.16M | 31,500 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-02-10 | 2015-02-12 | 11,200 | $103.66 | $1.16M | 52,200 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2015-01-27 | 2015-01-29 | 28,706 | — | $0 | 107,990 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2015-01-27 | 2015-01-29 | 7,294 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2015-01-27 | 2015-01-29 | 28,706 | $9.39 | $269.5K | 67,500 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-01-27 | 2015-01-29 | 17,200 | $104.93 | $1.80M | 50,300 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-01-27 | 2015-01-29 | 18,800 | $105.67 | $1.99M | 31,500 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2015-01-27 | 2015-01-29 | 7,294 | $10.59 | $77.2K | 38,794 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-12-03 | 2014-12-04 | 1,580 | $113.00 | $178.5K | 31,500 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2014-06-27 | 2014-07-01 | 4,792 | — | $0 | 4,792 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2014-06-27 | 2014-07-01 | 2,250 | — | $0 | 33,080 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-06-20 | 2014-06-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-06-20 | 2014-06-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2014-02-18 | 2014-02-19 | 40,000 | — | $0 | 7,294 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-18 | 2014-02-19 | 15,000 | $82.33 | $1.23M | 52,230 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-18 | 2014-02-19 | 3,600 | $81.45 | $293.2K | 67,230 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-18 | 2014-02-19 | 21,400 | $83.34 | $1.78M | 30,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2014-02-18 | 2014-02-19 | 40,000 | $10.59 | $423.6K | 70,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2014-02-11 | 2014-02-12 | 40,000 | — | $0 | 47,294 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-11 | 2014-02-12 | 4,500 | $79.73 | $358.8K | 66,330 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2014-02-11 | 2014-02-12 | 40,000 | $10.59 | $423.6K | 70,830 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-11 | 2014-02-12 | 22,200 | $80.66 | $1.79M | 44,130 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-11 | 2014-02-12 | 13,300 | $81.48 | $1.08M | 30,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2014-02-05 | 2014-02-06 | 40,000 | — | $0 | 87,294 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-05 | 2014-02-06 | 2,800 | $74.55 | $208.7K | 30,830 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-05 | 2014-02-06 | 21,800 | $73.66 | $1.61M | 33,630 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-02-05 | 2014-02-06 | 15,400 | $72.99 | $1.12M | 55,430 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2014-02-05 | 2014-02-06 | 40,000 | $10.59 | $423.6K | 70,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2014-01-28 | 2014-01-29 | 40,000 | — | $0 | 127,294 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-28 | 2014-01-29 | 31,600 | $75.58 | $2.39M | 30,930 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-28 | 2014-01-29 | 8,300 | $74.84 | $621.2K | 62,530 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-28 | 2014-01-29 | 100 | $76.22 | $7.6K | 30,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2014-01-28 | 2014-01-29 | 40,000 | $10.59 | $423.6K | 70,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2014-01-21 | 2014-01-23 | 40,000 | — | $0 | 167,294 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-21 | 2014-01-23 | 13,814 | $76.64 | $1.06M | 31,830 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-21 | 2014-01-23 | 25,186 | $76.04 | $1.92M | 45,644 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2014-01-21 | 2014-01-23 | 40,000 | $10.59 | $423.6K | 70,830 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-21 | 2014-01-23 | 100 | $78.76 | $7.9K | 30,830 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2014-01-21 | 2014-01-23 | 900 | $77.67 | $69.9K | 30,930 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2013-12-03 | 2013-12-04 | 5,425 | $62.66 | $339.9K | 30,830 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2013-11-07 | 2013-11-12 | 2,839 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2013-11-07 | 2013-11-12 | 2,765 | $0.78 | $2.2K | 36,255 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2012-12-17 | 2012-12-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer | 2012-12-10 | 2012-12-11 | 2,465 | $54.00 | $133.1K | 43,084 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer | 2012-12-10 | 2012-12-11 | 2,660 | $54.78 | $145.7K | 40,424 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2012-12-07 | 2012-12-11 | 9,000 | — | $0 | 45,549 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-10-03 | 2012-10-03 | 5,100 | — | $0 | 88,832 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-10-03 | 2012-10-03 | 5,100 | $6.74 | $34.4K | 41,649 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-10-03 | 2012-10-03 | 5,100 | $51.08 | $260.5K | 36,549 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-10-02 | 2012-10-03 | 6,068 | — | $0 | 93,932 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-10-02 | 2012-10-03 | 3,332 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-10-02 | 2012-10-03 | 9,400 | $57.08 | $536.6K | 36,549 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-10-02 | 2012-10-03 | 6,068 | $6.74 | $40.9K | 45,949 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-10-02 | 2012-10-03 | 3,332 | $5.88 | $19.6K | 39,881 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-10-01 | 2012-10-03 | 5,500 | — | $0 | 3,332 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-10-01 | 2012-10-03 | 5,500 | $57.04 | $313.7K | 36,549 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-10-01 | 2012-10-03 | 5,500 | $5.88 | $32.3K | 42,049 | SEC↗ |
| MDVN MEDIVATION, INC. | F Tax w/h | 2012-09-28 | 2012-10-02 | 6,473 | $56.35 | $364.8K | 15,038 | SEC↗ |
| MDVN MEDIVATION, INC. | F Tax w/h | 2012-09-28 | 2012-10-03 | 6,473 | $56.35 | $364.8K | 36,549 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-09-07 | 2012-09-11 | 20,000 | — | $0 | 44,416 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-09-07 | 2012-09-11 | 13,400 | $105.37 | $1.41M | 28,111 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-09-07 | 2012-09-11 | 6,600 | $106.50 | $702.9K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-09-07 | 2012-09-11 | 20,000 | $11.76 | $235.2K | 41,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-07-02 | 2012-07-05 | 10,000 | — | $0 | 64,416 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-07-02 | 2012-07-05 | 10,000 | $11.76 | $117.6K | 31,511 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-07-02 | 2012-07-05 | 10,000 | $94.11 | $941.1K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-05-24 | 2012-05-24 | 9,400 | — | $0 | 74,416 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-05-24 | 2012-05-24 | 9,400 | $11.76 | $110.5K | 30,911 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-05-24 | 2012-05-24 | 9,400 | $89.17 | $838.2K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-05-22 | 2012-05-24 | 600 | — | $0 | 83,816 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-05-22 | 2012-05-24 | 600 | $89.16 | $53.5K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-05-22 | 2012-05-24 | 600 | $11.76 | $7.1K | 22,111 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-05-14 | 2012-05-16 | 10,000 | — | $0 | 84,416 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-05-14 | 2012-05-16 | 10,000 | $11.76 | $117.6K | 31,511 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-05-14 | 2012-05-16 | 10,000 | $84.31 | $843.1K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-04-27 | 2012-05-01 | 10,000 | $80.16 | $801.6K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-04-27 | 2012-05-01 | 10,000 | $11.76 | $117.6K | 31,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-03-08 | 2012-05-01 | 10,000 | — | $0 | 94,416 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-03-08 | 2012-03-12 | 10,000 | — | $0 | 104,416 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-03-08 | 2012-03-12 | 10,000 | $11.76 | $117.6K | 31,511 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-03-08 | 2012-03-12 | 10,000 | $75.10 | $751.0K | 21,511 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-02-08 | 2012-02-09 | 19,193 | — | $0 | 114,416 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-08 | 2012-02-09 | 29,100 | $69.16 | $2.01M | 8,093 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-08 | 2012-02-09 | 19,900 | $68.35 | $1.36M | 37,193 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-02-08 | 2012-02-09 | 19,193 | $11.76 | $225.7K | 57,093 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-08 | 2012-02-09 | 2,193 | $71.25 | $156.3K | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-08 | 2012-02-09 | 5,900 | $70.16 | $413.9K | 2,193 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2012-02-07 | 2012-02-09 | 16,391 | — | $0 | 133,609 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-07 | 2012-02-09 | 400 | $73.17 | $29.3K | 37,900 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-07 | 2012-02-09 | 15,997 | $71.30 | $1.14M | 60,310 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-07 | 2012-02-09 | 4,500 | $70.32 | $316.4K | 76,307 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2012-02-07 | 2012-02-09 | 16,391 | $11.76 | $192.8K | 80,807 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2012-02-07 | 2012-02-09 | 22,010 | $72.20 | $1.59M | 38,300 | SEC↗ |